Santhera Pharmaceuticals
SANN.SW
#7954
Rank
HK$1.75 B
Marketcap
HK$139.15
Share price
3.49%
Change (1 day)
70.75%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -HK$291.11

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$97.99. In 2022 the company made an earnings per share (EPS) of -HK$97.99 an increase over its 2021 EPS that were of -HK$137.53.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-HK$97.99-28.75%
2021-HK$137.53-69.23%
2020-HK$446.98222.64%
2019-HK$138.54-77.65%
2018-HK$619.85-5.34%
2017-HK$654.8152.2%
2016-HK$430.22-593.67%
2015HK$87.15-165.72%
2014-HK$132.61-2.15%
2013-HK$135.52-81.35%
2012-HK$726.7215.64%
2011-HK$628.42145.81%
2010-HK$255.65-53.37%
2009-HK$548.27-152.24%
2008HK$1,049-270.36%
2007-HK$616.02-33.09%
2006-HK$920.67